StockNasdaqGSBIIB
Biogen
$226.36
-0.94 (-0.41%)today
Valuation & earnings
- P/E ratio
- 40.28
- Forward P/E
- 13.69
- EPS (ttm)
- $5.62
- Forward EPS
- $16.54
- Price/book
- 1.77
- PEG ratio
- 2.35
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 10B
- Revenue growth
- 3.4%
- Profit margin
- 8.32%
- Return on equity
- 4.58%
- Total cash
- 1.3B
- Total debt
- 8.4B
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 3.88 | 4.81 | +23.88% |
| Dec 31, 2025 | 1.62 | 1.99 | +23.18% |
| Mar 31, 2026 | 2.95 | 3.57 | +20.93% |
| Jun 30, 2026 | 2.03 | 3.6 | +77.38% |
Next earnings date: Oct 28, 2026
Analyst view
Consensus ratingBuy35 analysts
Strong buy 3Buy 19Hold 12Sell 1
12-month price targetsImplied upside: +5.22%
175
238.18
300
LowCurrent priceHigh
Latest news
(English)How Investors May Respond To Biogen (BIIB) Advancing At-Home LEQEMBI Pen And Kidney Disease Data
Simply Wall St.Sep 23, 2026
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets
TIKRSep 23, 2026
Biogen (BIIB) Posts New Kidney Trial Data, Is It Still 5% Undervalued?
Simply Wall St.Sep 23, 2026
Novo Nordisk shares plunge over 7% as new targets fail to reassure investors
ProactiveSep 21, 2026
Is Biogen Stock Outperforming the S&P 500?
BarchartSep 16, 2026
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
Insider MonkeySep 15, 2026
Related products
How visible is Biogen in AI search?
We ask AI search engines about Biogen and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Biogen yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.